0

Rhythm Disorders and Devices Collection
 1-20 of 47 Articles
ACP Journal Club |  19 August 2014
In atrial fibrillation, dabigatran had similar efficacy to warfarin but caused less bleeding in higher GFR
Sajiram Sarvananthan, MD; Prakash P. Punjabi, MD
Ann Intern Med. 2014;161(4):JC7. doi:10.7326/0003-4819-161-4-201408190-02007
ACP Journal Club |  17 June 2014
In AF, apixaban reduced stroke or systemic embolism compared with warfarin, regardless of patient age
Mukul Sharma, MD; Kanjana Perera, MD
Ann Intern Med. 2014;160(12):JC7. doi:10.7326/0003-4819-160-12-201406170-02007
ACP Journal Club |  20 May 2014
In anticoagulated patients with AF, HAS-BLED predicted major bleeding better than CHADS2 and CHA2DS2-VASc
Maura Marcucci, MD
Ann Intern Med. 2014;160(10):JC13. doi:10.7326/0003-4819-160-10-201405200-02013
ACP Journal Club |  20 May 2014
Ablation reduced recurrent atrial tachyarrhythmia more than antiarrhythmic drugs in paroxysmal AF
Yee C. Lau, MD; Gregory Y.H. Lip, MD
Ann Intern Med. 2014;160(10):JC5. doi:10.7326/0003-4819-160-10-201405200-02005
ACP Journal Club |  15 April 2014
Review: Dabigatran does not differ from vitamin K antagonists for mortality or major bleeding
Alex Gallus, MB, FRACP, FRCPA
Ann Intern Med. 2014;160(8):JC5. doi:10.7326/0003-4819-160-8-201404150-02005
ACP Journal Club |  18 March 2014
In AF or VTE, acenocoumarol or phenprocoumon dosing by genotype did not affect time in therapeutic range
Andrew Dunn, MD, SFHM, MPH, FACP
Ann Intern Med. 2014;160(6):JC10. doi:10.7326/0003-4819-160-6-201403180-02010
ACP Journal Club |  18 March 2014
In AF or VTE, warfarin dosing by genotype improved time in therapeutic range but not clinical outcomes
Andrew Dunn, MD, MPH, SFHM, FACP
Ann Intern Med. 2014;160(6):JC9. doi:10.7326/0003-4819-160-6-201403180-02009
ACP Journal Club |  18 March 2014
Warfarin dosing by genotype did not improve time in therapeutic range
Andrew Dunn, MD, MPH, SFHM, FACP
Ann Intern Med. 2014;160(6):JC8. doi:10.7326/0003-4819-160-6-201403180-02008
ACP Journal Club |  18 March 2014
Edoxaban was noninferior to warfarin for preventing stroke or systemic embolism in atrial fibrillation
Stacy A. Johnson, MD; Matthew T. Rondina, MD
Ann Intern Med. 2014;160(6):JC7. doi:10.7326/0003-4819-160-6-201403180-02007
ACP Journal Club |  18 March 2014
In overweight or obese patients with atrial fibrillation, a weight reduction program reduced symptoms
D. George Wyse, MD, PhD, FACP
Ann Intern Med. 2014;160(6):JC6. doi:10.7326/0003-4819-160-6-201403180-02006
ACP Journal Club |  18 February 2014
In out-of-hospital cardiac arrest, mechanical CPR did not improve survival compared with manual CPR
Eddy Lang, MD
Ann Intern Med. 2014;160(4):JC5. doi:10.7326/0003-4819-160-4-201402180-02005
ACP Journal Club |  18 February 2014
Review: Novel oral anticoagulants reduce stroke more than ASA in nonvalvular atrial fibrillation
Ignacio Neumann, MD, MSc; Romina Brignardello-Petersen, DDS, MSc; Gordon Guyatt, MD
Ann Intern Med. 2014;160(4):JC3. doi:10.7326/0003-4819-160-4-201402180-02003
ACP Journal Club |  17 December 2013
Review: In noncardiac surgery, β-blockers started before surgery increase 30-day mortality
Prashant Vaishnava, MD; Kim Eagle, MD, MACC
Ann Intern Med. 2013;159(12):JC2. doi:10.7326/0003-4819-159-12-201312170-02002
ACP Journal Club |  19 November 2013
Combined vasopressin, steroids, and epinephrine improved survival in in-hospital cardiac arrest
Kenneth A. Ballew, MD, MS
Ann Intern Med. 2013;159(10):JC4. doi:10.7326/0003-4819-159-10-201311190-02004
ACP Journal Club |  20 August 2013
Warfarin continuation was better than heparin bridging during pacemaker or ICD surgery
Thomas DeLoughery, MD, FACP, FAWM
Ann Intern Med. 2013;159(4):JC7. doi:10.7326/0003-4819-159-4-201308200-02007
ACP Journal Club |  16 July 2013
Apixaban reduced stroke or systemic embolism in AF more than warfarin regardless of type or duration of AF
Sara Vazquez, PharmD; Matthew T. Rondina, MD
Ann Intern Med. 2013;159(2):JC8. doi:10.7326/0003-4819-159-2-201307160-02008
ACP Journal Club |  16 April 2013
Adding renal dysfunction to CHADS2 did not improve prediction of stroke or systemic embolism in AF
Catherine M. Clase, MD; Deborah L. Zimmerman, MD; Benjamin K. A. Thomson, MD
Ann Intern Med. 2013;158(8):JC13. doi:10.7326/0003-4819-158-8-201304160-02013
ACP Journal Club |  18 December 2012
Apixaban reduced stroke or systemic embolism more than warfarin in AF regardless of renal function
Melvyn M. Jones, MB, BS, MD, MRCGP
Ann Intern Med. 2012;157(12):JC6-7. doi:10.7326/0003-4819-157-12-201212180-02007
ACP Journal Club |  16 October 2012
Various risk stratification schemes predict ischemic stroke and bleeding in atrial fibrillation
Brian F. Gage, MD, MSc; Ambar Andrade, MD
Ann Intern Med. 2012;157(8):JC4-13. doi:10.7326/0003-4819-157-8-201210160-02013
ACP Journal Club |  18 September 2012
Short-term was less effective than long-term flecainide for preventing recurrent AF after cardioversion
D. George Wyse, MD, PhD, FRCPC, FACP
Ann Intern Med. 2012;157(6):JC3-9. doi:10.7326/0003-4819-157-6-201209180-02009
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)